Exact Mass: 520.3876

Exact Mass Matches: 520.3876

Found 462 metabolites which its exact mass value is equals to given mass value 520.3876, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

1-Linoleoyl-sn-glycero-3-phosphocholine

1-Linoleoyl-sn-glycero-3-phosphocholine

C26H51NO7P+ (520.3403)


   

Cucurbitacin P

Cucurbitacin IIb

C30H48O7 (520.34)


   

Ginsenoyne A linoleate

8-[3-(Hept-6-en-1-yl)oxiran-2-yl]oct-1-en-4,6-diyn-3-yl (9E,12E)-octadeca-9,12-dienoic acid

C35H52O3 (520.3916)


Ginsenoyne A linoleate is found in tea. Ginsenoyne A linoleate is isolated from ginseng. Isolated from ginseng. Ginsenoyne A linoleate is found in tea.

   

Cyclopassifloic acid B

15-[5,6-dihydroxy-5-(propan-2-yl)hexan-2-yl]-4,6-dihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O6 (520.3764)


Cyclopassifloic acid B is found in fruits. Cyclopassifloic acid B is a constituent of Passiflora edulis (passion fruit). Constituent of Passiflora edulis (passion fruit). Cyclopassifloic acid B is found in fruits.

   

LysoPA(24:1(15Z)/0:0)

{2-hydroxy-3-[(15Z)-tetracos-15-enoyloxy]propoxy}phosphonic acid

C27H53O7P (520.3529)


LysoPA(24:1(15Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(24:1(15Z)/0:0), in particular, consists of one chain of nervonic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

   

Chenodeoxycholyllysine

6-Amino-2-[(4-{5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}-1-hydroxypentylidene)amino]hexanoate

C30H52N2O5 (520.3876)


Chenodeoxycholyllysine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholyllysine consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Lysine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholyllysine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholyllysine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Chenodeoxycholylglutamine

2-[(4-{5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}-1-hydroxypentylidene)amino]-4-(C-hydroxycarbonimidoyl)butanoate

C29H48N2O6 (520.3512)


Chenodeoxycholylglutamine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholylglutamine consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Glutamine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholylglutamine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholylglutamine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Deoxycholyllysine

6-Amino-2-[(4-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}-1-hydroxypentylidene)amino]hexanoate

C30H52N2O5 (520.3876)


Deoxycholyllysine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholyllysine consists of the bile acid deoxycholic acid conjugated to the amino acid Lysine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholyllysine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholyllysine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Deoxycholylglutamine

4-carbamoyl-2-(4-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)butanoic acid

C29H48N2O6 (520.3512)


Deoxycholylglutamine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholylglutamine consists of the bile acid deoxycholic acid conjugated to the amino acid Glutamine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholylglutamine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholylglutamine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Anipamil

2-(3-methoxyphenyl)-2-(3-{[2-(3-methoxyphenyl)ethyl](methyl)amino}propyl)tetradecanenitrile

C34H52N2O2 (520.4029)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

DG(8:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C31H52O6 (520.3764)


DG(8:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C31H52O6 (520.3764)


DG(8:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl octanoic acid

C31H52O6 (520.3764)


DG(8:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/8:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl octanoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,11Z,14Z)-O(8,9)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl octanoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/8:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl octanoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl octanoic acid

C31H52O6 (520.3764)


DG(8:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/8:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl octanoic acid

C31H52O6 (520.3764)


DG(20:3(8Z,11Z,14Z)-O(5,6)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl octanoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/8:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl octanoic acid

C31H52O6 (520.3764)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-hydroxy-3-(octanoyloxy)propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoate

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoate

C31H52O6 (520.3764)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Platycodigenin

(4aR,5R,6aR,6aS,6bR,8aR,10R,11S,12aR,14bS)-5,10,11-trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


5,10,11-Trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid is a natural product found in Platycodon grandiflorus with data available. Platicodigenin isolated from platycodon grandiflorum. Platicodigenin isolated from platycodon grandiflorum.

   

Cucurbitacin IIb

(2S,3S,8S,9R,10R,13R,14S,16R,17R)-17-[(2R)-2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl]-2,3,16-trihydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one

C30H48O7 (520.34)


Cucurbitacin IIb is a natural product found in Physocarpus capitatus, Begonia heracleifolia, and other organisms with data available. Cucurbitacin IIb is an active component isolated from Hemsleya amabilis, induces apoptosis with anti-inflammatory activity. Cucurbitacin IIb inhibits phosphorylation of STAT3, JNK and Erk1/2, enhances the phosphorylation of IκB and NF-κB (p65), blocks nuclear translocation of NF-κB (p65) and decreases mRNA levels of IκBα and TNF-α[1]. Cucurbitacin IIb is an active component isolated from Hemsleya amabilis, induces apoptosis with anti-inflammatory activity. Cucurbitacin IIb inhibits phosphorylation of STAT3, JNK and Erk1/2, enhances the phosphorylation of IκB and NF-κB (p65), blocks nuclear translocation of NF-κB (p65) and decreases mRNA levels of IκBα and TNF-α[1].

   

Gamboukokoensein A

1alpha,2alpha,3beta,19alpha,23-Pentahydroxyurs-12-en-28-oic acid

C30H48O7 (520.34)


   

Hippuristerol F

Hippuristerol F

C31H52O6 (520.3764)


   

20-Hydroxyecdysone 2,3-monoacetonide

(+)-20-Hydroxyecdysone 2,3-monoacetonide

C30H48O7 (520.34)


   

Inokosterone 20,22-acetonide

Inokosterone 20,22-acetonide

C30H48O7 (520.34)


   

Cordianol C

Cordianol C

C31H52O6 (520.3764)


   

Ecdysterone 20,22-monoacetonide

(+)-20-Hydroxyecdysone-20,22-monoacetonide

C30H48O7 (520.34)


Origin: Plant; SubCategory_DNP: The sterols, Cholestanes

   

Alisol P

Alisol P

C30H48O7 (520.34)


   

Ekeberin D1

Ekeberin D1

C32H56O5 (520.4128)


   

Cordianol I

Cordianol I

C31H52O6 (520.3764)


   

21-O-Methyltoosendanpentol

21-O-Methyltoosendanpentol

C31H52O6 (520.3764)


   

N-3-Benzoyl-buxidienin-F

N-3-Benzoyl-buxidienin-F

C33H48N2O3 (520.3665)


   

Trachelosperogenin B

Trachelosperogenin B

C30H48O7 (520.34)


A pentacyclic triterpenoid that is urs-12-ene carrying a carboxy substituent at position 28 as well as five hydroxy substituents at positions 2, 3, 19, 23 and 24 (the 2alpha,3beta stereoisomer).

   
   

N-Benzoyl-cycloprotobuxolin-C

N-Benzoyl-cycloprotobuxolin-C

C34H52N2O2 (520.4029)


   
   

Hippurin 1

Hippurin 1

C30H48O7 (520.34)


   

combregenin

combregenin

C30H48O7 (520.34)


   

asbestinin-7

asbestinin-7

C30H48O7 (520.34)


   

polyporusterone I

polyporusterone I

C30H48O7 (520.34)


   

(-)-buxanoldine

(-)-buxanoldine

C33H48N2O3 (520.3665)


   

21-O-methyl toosendanpentol|21-O-methyltoosendapentol

21-O-methyl toosendanpentol|21-O-methyltoosendapentol

C31H52O6 (520.3764)


   

icacinic acid

icacinic acid

C30H48O7 (520.34)


   

3-Benzoylcyclomicrophylline

3-Benzoylcyclomicrophylline

C33H48N2O3 (520.3665)


   

berkleasmin A

berkleasmin A

C30H48O7 (520.34)


   

ajugasterone C-20,22-monoacetonide

ajugasterone C-20,22-monoacetonide

C30H48O7 (520.34)


   

aglaiabbreviatin F

aglaiabbreviatin F

C32H56O5 (520.4128)


   
   

3-acetyl-2-desacetylhippurin-1

3-acetyl-2-desacetylhippurin-1

C30H48O7 (520.34)


   

(2beta,3beta,16beta,21beta)-2,3,16,21,23-Pentahydroxy-12-oleanen-28-oic acid

(2beta,3beta,16beta,21beta)-2,3,16,21,23-Pentahydroxy-12-oleanen-28-oic acid

C30H48O7 (520.34)


   

petuniasterone H2

petuniasterone H2

C30H48O7 (520.34)


   

crassumtocopherol B

crassumtocopherol B

C31H52O6 (520.3764)


   

polypodine B-20,22-monoacetonide

polypodine B-20,22-monoacetonide

C30H48O7 (520.34)


   

halicrasterol B

halicrasterol B

C31H52O6 (520.3764)


   

(1beta,2alpha,3beta,16beta,19beta)-1,2,3,16,19-pentahydroxyolean-12-en-28-oic acid

(1beta,2alpha,3beta,16beta,19beta)-1,2,3,16,19-pentahydroxyolean-12-en-28-oic acid

C30H48O7 (520.34)


   

agladoral B

agladoral B

C31H52O6 (520.3764)


   

(1beta,2alpha,3beta,19beta,23)-1,2,3,19,23-pentahydroxyolean-12-en-28-oic acid

(1beta,2alpha,3beta,19beta,23)-1,2,3,19,23-pentahydroxyolean-12-en-28-oic acid

C30H48O7 (520.34)


   

laevigin A

laevigin A

C30H48O7 (520.34)


   

iriomoteolide-1c

iriomoteolide-1c

C30H48O7 (520.34)


   

methyl 19-isobutyryldesacetylacamptoate

methyl 19-isobutyryldesacetylacamptoate

C30H48O7 (520.34)


   

Plagiospirolide C

Plagiospirolide C

C35H52O3 (520.3916)


   

Plagiospirolide D

Plagiospirolide D

C35H52O3 (520.3916)


   

3alpha-O-acetyl-20,24,25-trihydroxydammarane

3alpha-O-acetyl-20,24,25-trihydroxydammarane

C32H56O5 (520.4128)


   

2alpha-(3-angeloyloxy-2-hydroxy-2-methyl butyryloxy)-labd-7-en-15-oic acid|2alpha-<3-angeloyloxy-2-hydroxy-2-methyl butyryloxy>-labd-7-en-15-oic acid

2alpha-(3-angeloyloxy-2-hydroxy-2-methyl butyryloxy)-labd-7-en-15-oic acid|2alpha-<3-angeloyloxy-2-hydroxy-2-methyl butyryloxy>-labd-7-en-15-oic acid

C30H48O7 (520.34)


   

16alpha-hydroxy protobassic acid|16alpha-hydroxyprotobassic acid|2beta,3beta,6beta,16alpha,23-pentahydroxyolean-12-en-28-oic acid

16alpha-hydroxy protobassic acid|16alpha-hydroxyprotobassic acid|2beta,3beta,6beta,16alpha,23-pentahydroxyolean-12-en-28-oic acid

C30H48O7 (520.34)


   

Ganoderic Acid C2

Ganoderic Acid C2

C30H48O7 (520.34)


   

Lysine conjugated deoxycholic acid putative

Lysine conjugated deoxycholic acid putative

C30H52N2O5 (520.3876)


   

Glutamine chenodeoxycholic acid

Glutamine chenodeoxycholic acid

C29H48N2O6 (520.3512)


   

(5Z,7E)-(1S,3R)-11-(4-hydroxymethylphenyl)-9,10-seco-5,7,9(11),10(19)-cholestatetraene-1,3,25-triol

1α,25-dihydroxy-11-(4-hydroxymethylphenyl)-9,11-didehydrovitamin D3 / 1α,25-dihydroxy-11-(4-hydroxymethylphenyl)-9,11-didehydrocholecalciferol

C34H48O4 (520.3552)


   

U-83836E

(2R)-[[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]methyl]-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-6-ol, hydrochloride

C30H44N6O2 (520.3526)


   

Linoleic Acid-biotin

9Z,12Z-octadecadienoyl-N-biotinoyl-1,5-diaminopentane

C28H48N4O3S (520.3447)


   

Cyclopassifloic acid B

15-[5,6-dihydroxy-5-(propan-2-yl)hexan-2-yl]-4,6-dihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0^{1,3}.0^{3,8}.0^{12,16}]octadecane-7-carboxylic acid

C31H52O6 (520.3764)


   

Ginsenoyne A linoleate

8-[3-(hept-6-en-1-yl)oxiran-2-yl]oct-1-en-4,6-diyn-3-yl (9E,12E)-octadeca-9,12-dienoate

C35H52O3 (520.3916)


   

Bellericagenin B

(2?,3?,5?,9?,18?,19?)-2,3,19,23,24-Pentahydroxyolean-12-en-28-oic acid

C30H48O7 (520.34)


   

FOH 35:10;O2

Pentatriaconta-20Z,31E-dien-2,4,22,34-tetrayne-1,6,33-triol

C35H52O3 (520.3916)


   

Cucurbitacin C5

3beta,16alpha,19,20beta,25-pentahydroxycucurbit-5-en-11,22-dione

C30H48O7 (520.34)


   

Superecdysone C

(20S,22R)-3beta-(2R-hydroxypropionyl)-14alpha,22R,25-trihydroxy-5beta-cholest-7-en-6-one

C30H48O7 (520.34)


   

Superecdysone D

(20S,22R)-22R-(2R-hydroxypropionyl)-3beta,14alpha,22R,25-trihydroxy-5beta-cholest-7-en-6-one

C30H48O7 (520.34)


   

Hippurin-1

(22R)-1alpha-acetoxy-24S-methyl-5alpha-furospirostan-3alpha,11beta,20R-triol

C30H48O7 (520.34)


   

ST 30:3;O7

(22S)-1alpha-acetoxy-5alpha-furospirostan-3alpha,11beta,20R-triol

C30H48O7 (520.34)


   

triton(r) x-100, hydrogenated

triton(r) x-100, hydrogenated

C28H56O8 (520.3975)


   

Vitamin K1(25)

Vitamin K1(25)

C36H56O2 (520.428)


   

1-Linoleoylglycerophosphocholine

1-Linoleoylglycerophosphocholine

C26H51NO7P+ (520.3403)


   

Deoxycholylglutamine

Deoxycholylglutamine

C29H48N2O6 (520.3512)


   

Chenodeoxycholylglutamine

Chenodeoxycholylglutamine

C29H48N2O6 (520.3512)


   

DG(8:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(8:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C31H52O6 (520.3764)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/8:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(8:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C31H52O6 (520.3764)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/8:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(8:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C31H52O6 (520.3764)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/8:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(8:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C31H52O6 (520.3764)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/8:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(8:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C31H52O6 (520.3764)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/8:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(8:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C31H52O6 (520.3764)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/8:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(8:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C31H52O6 (520.3764)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/8:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(8:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C31H52O6 (520.3764)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/8:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(8:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/8:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C31H52O6 (520.3764)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/8:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(8:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/8:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(8:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/8:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(8:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/8:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(8:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C31H52O6 (520.3764)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/8:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(8:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/8:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(8:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C31H52O6 (520.3764)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/8:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/8:0)

C31H52O6 (520.3764)


   

Linoleoyl phophatidylcholine

Linoleoyl phophatidylcholine

C26H51NO7P+ (520.3403)


   

Verrucoside

Verrucoside

C30H48O7 (520.34)


A natural product found in Eunicella verrucosa.

   

4-tert-butyl-N-[3-[4-[3-[[(4-tert-butylphenyl)-oxomethyl]amino]propyl]-1-piperazinyl]propyl]benzamide

4-tert-butyl-N-[3-[4-[3-[[(4-tert-butylphenyl)-oxomethyl]amino]propyl]-1-piperazinyl]propyl]benzamide

C32H48N4O2 (520.3777)


   

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

4-(dimethylamino)-N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

4-(dimethylamino)-N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C28H48N4O5 (520.3625)


   

1,2-dihexanoyl-3-(7Z,10Z,13Z-hexadecatrienoyl)-glycerol

1,2-dihexanoyl-3-(7Z,10Z,13Z-hexadecatrienoyl)-glycerol

C31H52O6 (520.3764)


   

1-oleoyl-3-alpha-D-galactosyl-sn-glycerol

1-oleoyl-3-alpha-D-galactosyl-sn-glycerol

C27H52O9 (520.3611)


   

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

4-(dimethylamino)-N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

4-(dimethylamino)-N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C28H48N4O5 (520.3625)


   

4-(dimethylamino)-N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

4-(dimethylamino)-N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C28H48N4O5 (520.3625)


   

4-(dimethylamino)-N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

4-(dimethylamino)-N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C28H48N4O5 (520.3625)


   

4-(dimethylamino)-N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

4-(dimethylamino)-N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C28H48N4O5 (520.3625)


   

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea

C28H48N4O5 (520.3625)


   

4-(dimethylamino)-N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

4-(dimethylamino)-N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C28H48N4O5 (520.3625)


   

N-hexanoylsphingosine-1-phosphoethanolamine

N-hexanoylsphingosine-1-phosphoethanolamine

C26H53N2O6P (520.3641)


An N-acylsphingosine-1-phosphoethanolamine in which the N-acyl group is specified as hexanoyl.

   

N-caproylsphingosine-1-phosphoethanolamine zwitterion

N-caproylsphingosine-1-phosphoethanolamine zwitterion

C26H53N2O6P (520.3641)


   

2-[Hydroxy-(2-hydroxy-3-octadeca-9,12-dienoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(2-hydroxy-3-octadeca-9,12-dienoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C26H51NO7P+ (520.3403)


   

2-[hydroxy-[(2R)-2-hydroxy-3-[(2E,4E)-octadeca-2,4-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R)-2-hydroxy-3-[(2E,4E)-octadeca-2,4-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C26H51NO7P+ (520.3403)


   

2-[hydroxy-[(2R)-2-hydroxy-3-[(1Z,12Z)-nonadeca-1,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R)-2-hydroxy-3-[(1Z,12Z)-nonadeca-1,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C27H55NO6P+ (520.3767)


   

(2-hydroxy-3-phosphonooxypropyl) (Z)-tetracos-13-enoate

(2-hydroxy-3-phosphonooxypropyl) (Z)-tetracos-13-enoate

C27H53O7P (520.3529)


   

Mgdg O-9:0_9:0

Mgdg O-9:0_9:0

C27H52O9 (520.3611)


   

Mgdg O-14:0_4:0

Mgdg O-14:0_4:0

C27H52O9 (520.3611)


   

Mgdg O-8:0_10:0

Mgdg O-8:0_10:0

C27H52O9 (520.3611)


   

Mgdg O-13:0_5:0

Mgdg O-13:0_5:0

C27H52O9 (520.3611)


   

Mgdg O-12:0_6:0

Mgdg O-12:0_6:0

C27H52O9 (520.3611)


   

Mgdg O-16:0_2:0

Mgdg O-16:0_2:0

C27H52O9 (520.3611)


   

Mgdg O-11:0_7:0

Mgdg O-11:0_7:0

C27H52O9 (520.3611)


   

Mgdg O-15:0_3:0

Mgdg O-15:0_3:0

C27H52O9 (520.3611)


   

Mgdg O-10:0_8:0

Mgdg O-10:0_8:0

C27H52O9 (520.3611)


   

PE-Cer 12:1;2O/12:0

PE-Cer 12:1;2O/12:0

C26H53N2O6P (520.3641)


   

[(E)-2-(dodecanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(dodecanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[(E)-2-(butanoylamino)-3-hydroxyheptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(butanoylamino)-3-hydroxyheptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[(E)-3-hydroxy-2-(nonanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(nonanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[(E)-2-(hexanoylamino)-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexanoylamino)-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[(E)-2-acetamido-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-acetamido-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[(E)-3-hydroxy-2-(octanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(octanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[(E)-3-hydroxy-2-(pentanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[(E)-3-hydroxy-2-(tridecanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(tridecanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[(E)-2-(heptanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[(E)-3-hydroxy-2-(propanoylamino)octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(propanoylamino)octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[(E)-3-hydroxy-2-(undecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(undecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[(E)-2-(decanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(decanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

[3-carboxy-2-[(13Z,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(13Z,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropyl]-trimethylazanium

C32H58NO4+ (520.4366)


   

2-[hydroxy-[2-hydroxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-hydroxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C26H51NO7P+ (520.3403)


   

[1-carboxy-3-[2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C30H50NO6+ (520.3638)


   

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (9Z,12Z)-hexadeca-9,12-dienoate

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (9Z,12Z)-hexadeca-9,12-dienoate

C36H56O2 (520.428)


   

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H53N2O6P (520.3641)


   

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-12,15,18,21,24,27,30,33-octaenoic acid

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-12,15,18,21,24,27,30,33-octaenoic acid

C36H56O2 (520.428)


   

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C32H56O5 (520.4128)


   

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C32H56O5 (520.4128)


   

(1-hydroxy-3-undecanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

(1-hydroxy-3-undecanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C32H56O5 (520.4128)


   

Linoleoyllysophosphatidylcholine

Linoleoyllysophosphatidylcholine

C26H51NO7P+ (520.3403)


   

(1-hydroxy-3-nonanoyloxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

(1-hydroxy-3-nonanoyloxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C32H56O5 (520.4128)


   

(1-heptanoyloxy-3-hydroxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

(1-heptanoyloxy-3-hydroxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C32H56O5 (520.4128)


   

2-[hydroxy-[(2R)-3-hydroxy-2-[(9Z,12E)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R)-3-hydroxy-2-[(9Z,12E)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C26H51NO7P+ (520.3403)


   

2-[hydroxy-[(2R)-2-hydroxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R)-2-hydroxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C26H51NO7P+ (520.3403)


   

[(2S)-3-hydroxy-2-undecanoyloxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

[(2S)-3-hydroxy-2-undecanoyloxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C32H56O5 (520.4128)


   

2-[hydroxy-[3-hydroxy-2-[(4Z,7Z)-octadeca-4,7-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[(4Z,7Z)-octadeca-4,7-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C26H51NO7P+ (520.3403)


   

(3-hydroxy-2-tridecanoyloxypropyl) (9E,11E,13E)-hexadeca-9,11,13-trienoate

(3-hydroxy-2-tridecanoyloxypropyl) (9E,11E,13E)-hexadeca-9,11,13-trienoate

C32H56O5 (520.4128)


   

[3-hydroxy-2-[(E)-tridec-8-enoyl]oxypropyl] (4E,7E)-hexadeca-4,7-dienoate

[3-hydroxy-2-[(E)-tridec-8-enoyl]oxypropyl] (4E,7E)-hexadeca-4,7-dienoate

C32H56O5 (520.4128)


   

[1-carboxy-3-[2-hydroxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-hydroxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C30H50NO6+ (520.3638)


   

2-[hydroxy-[(2R)-2-hydroxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R)-2-hydroxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C26H51NO7P+ (520.3403)


   

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C32H56O5 (520.4128)


   

2-[[2-acetyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-acetyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C26H51NO7P+ (520.3403)


   

2-[hydroxy-[2-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C27H55NO6P+ (520.3767)


   

22-epi-Hippurin-1

22-epi-Hippurin-1

C30H48O7 (520.34)


   

N-hexanoylsphingosine-1-phosphoethanolamine zwitterion

N-hexanoylsphingosine-1-phosphoethanolamine zwitterion

C26H53N2O6P (520.3641)


An N-acylsphingosine-1-phosphoethanolamine zwitterion in which the N-acyl group is specified as hexanoyl.

   

DG(29:3)

DG(11:0_18:3)

C32H56O5 (520.4128)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(28:3)

TG(4:0_11:3_13:0)

C31H52O6 (520.3764)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(29:3)

TG(12:0(1)_6:0_11:3)

C32H56O5 (520.4128)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MGMG(18:0)

MGMG(18:0)

C27H52O9 (520.3611)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

FAHFA 10:2/O-24:7

FAHFA 10:2/O-24:7

C34H48O4 (520.3552)


   

FAHFA 10:3/O-24:6

FAHFA 10:3/O-24:6

C34H48O4 (520.3552)


   

FAHFA 11:2/O-23:7

FAHFA 11:2/O-23:7

C34H48O4 (520.3552)


   

FAHFA 11:3/O-23:6

FAHFA 11:3/O-23:6

C34H48O4 (520.3552)


   

FAHFA 12:2/O-22:7

FAHFA 12:2/O-22:7

C34H48O4 (520.3552)


   

FAHFA 12:3/O-22:6

FAHFA 12:3/O-22:6

C34H48O4 (520.3552)


   

FAHFA 12:4/O-22:5

FAHFA 12:4/O-22:5

C34H48O4 (520.3552)


   

FAHFA 13:2/O-21:7

FAHFA 13:2/O-21:7

C34H48O4 (520.3552)


   

FAHFA 13:3/O-21:6

FAHFA 13:3/O-21:6

C34H48O4 (520.3552)


   

FAHFA 13:4/O-21:5

FAHFA 13:4/O-21:5

C34H48O4 (520.3552)


   

FAHFA 14:3/O-20:6

FAHFA 14:3/O-20:6

C34H48O4 (520.3552)


   

FAHFA 14:4/O-20:5

FAHFA 14:4/O-20:5

C34H48O4 (520.3552)


   

FAHFA 15:3/O-19:6

FAHFA 15:3/O-19:6

C34H48O4 (520.3552)


   

FAHFA 15:4/O-19:5

FAHFA 15:4/O-19:5

C34H48O4 (520.3552)


   

FAHFA 15:5/O-19:4

FAHFA 15:5/O-19:4

C34H48O4 (520.3552)


   

FAHFA 16:3/O-18:6

FAHFA 16:3/O-18:6

C34H48O4 (520.3552)


   

FAHFA 16:4/O-18:5

FAHFA 16:4/O-18:5

C34H48O4 (520.3552)


   

FAHFA 16:5/O-18:4

FAHFA 16:5/O-18:4

C34H48O4 (520.3552)


   

FAHFA 17:4/O-17:5

FAHFA 17:4/O-17:5

C34H48O4 (520.3552)


   

FAHFA 17:5/O-17:4

FAHFA 17:5/O-17:4

C34H48O4 (520.3552)


   

FAHFA 18:4/O-16:5

FAHFA 18:4/O-16:5

C34H48O4 (520.3552)


   

FAHFA 18:5/O-16:4

FAHFA 18:5/O-16:4

C34H48O4 (520.3552)


   

FAHFA 18:6/O-16:3

FAHFA 18:6/O-16:3

C34H48O4 (520.3552)


   

FAHFA 19:4/O-15:5

FAHFA 19:4/O-15:5

C34H48O4 (520.3552)


   

FAHFA 19:5/O-15:4

FAHFA 19:5/O-15:4

C34H48O4 (520.3552)


   

FAHFA 19:6/O-15:3

FAHFA 19:6/O-15:3

C34H48O4 (520.3552)


   

FAHFA 20:5/O-14:4

FAHFA 20:5/O-14:4

C34H48O4 (520.3552)


   

FAHFA 20:6/O-14:3

FAHFA 20:6/O-14:3

C34H48O4 (520.3552)


   

FAHFA 21:5/O-13:4

FAHFA 21:5/O-13:4

C34H48O4 (520.3552)


   

FAHFA 21:6/O-13:3

FAHFA 21:6/O-13:3

C34H48O4 (520.3552)


   

FAHFA 21:7/O-13:2

FAHFA 21:7/O-13:2

C34H48O4 (520.3552)


   

FAHFA 22:5/O-12:4

FAHFA 22:5/O-12:4

C34H48O4 (520.3552)


   

FAHFA 22:6/O-12:3

FAHFA 22:6/O-12:3

C34H48O4 (520.3552)


   

FAHFA 22:7/O-12:2

FAHFA 22:7/O-12:2

C34H48O4 (520.3552)


   

FAHFA 23:6/O-11:3

FAHFA 23:6/O-11:3

C34H48O4 (520.3552)


   

FAHFA 23:7/O-11:2

FAHFA 23:7/O-11:2

C34H48O4 (520.3552)


   

FAHFA 24:6/O-10:3

FAHFA 24:6/O-10:3

C34H48O4 (520.3552)


   

FAHFA 24:7/O-10:2

FAHFA 24:7/O-10:2

C34H48O4 (520.3552)


   

FAHFA 25:6/O-9:3

FAHFA 25:6/O-9:3

C34H48O4 (520.3552)


   

FAHFA 25:7/O-9:2

FAHFA 25:7/O-9:2

C34H48O4 (520.3552)


   

FAHFA 26:7/O-8:2

FAHFA 26:7/O-8:2

C34H48O4 (520.3552)


   

FAHFA 34:9;O

FAHFA 34:9;O

C34H48O4 (520.3552)


   

FAHFA 8:2/O-26:7

FAHFA 8:2/O-26:7

C34H48O4 (520.3552)


   

FAHFA 9:2/O-25:7

FAHFA 9:2/O-25:7

C34H48O4 (520.3552)


   

FAHFA 9:3/O-25:6

FAHFA 9:3/O-25:6

C34H48O4 (520.3552)


   

DG 11:0_18:3

DG 11:0_18:3

C32H56O5 (520.4128)


   
   
   
   

PA O-14:1/10:0

PA O-14:1/10:0

C27H53O7P (520.3529)


   

PA O-20:0/4:1

PA O-20:0/4:1

C27H53O7P (520.3529)


   

PA O-20:1/4:0

PA O-20:1/4:0

C27H53O7P (520.3529)


   

PA O-22:1/2:0

PA O-22:1/2:0

C27H53O7P (520.3529)


   
   

PA P-14:0/10:0

PA P-14:0/10:0

C27H53O7P (520.3529)


   

PA P-14:0/10:0 or PA O-14:1/10:0

PA P-14:0/10:0 or PA O-14:1/10:0

C27H53O7P (520.3529)


   

PA P-20:0/4:0

PA P-20:0/4:0

C27H53O7P (520.3529)


   

PA P-20:0/4:0 or PA O-20:1/4:0

PA P-20:0/4:0 or PA O-20:1/4:0

C27H53O7P (520.3529)


   

PA P-22:0/2:0

PA P-22:0/2:0

C27H53O7P (520.3529)


   

PA P-22:0/2:0 or PA O-22:1/2:0

PA P-22:0/2:0 or PA O-22:1/2:0

C27H53O7P (520.3529)


   
   

PA P-24:0 or PA O-24:1

PA P-24:0 or PA O-24:1

C27H53O7P (520.3529)


   
   
   

CerPE 14:1;O2/10:0

CerPE 14:1;O2/10:0

C26H53N2O6P (520.3641)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

ST 24:1;O;GlcA

ST 24:1;O;GlcA

C30H48O7 (520.34)


   

ST 24:2;O2;Hex

ST 24:2;O2;Hex

C30H48O7 (520.34)


   

ST 25:1;O;Hex

ST 25:1;O;Hex

C31H52O6 (520.3764)


   

(1'r,3r,3as,4's,4as,6'r,7'r,8's,8as,9as,11's,13'r)-6'-hydroxy-7'-isopropyl-1',4',5,8a,11'-pentamethyl-4,4a,7,8,9,9a-hexahydro-3ah-spiro[naphtho[2,3-b]furan-3,15'-tetracyclo[11.2.1.0²,¹².0⁴,⁸]hexadecan]-2'(12')-en-2-one

(1'r,3r,3as,4's,4as,6'r,7'r,8's,8as,9as,11's,13'r)-6'-hydroxy-7'-isopropyl-1',4',5,8a,11'-pentamethyl-4,4a,7,8,9,9a-hexahydro-3ah-spiro[naphtho[2,3-b]furan-3,15'-tetracyclo[11.2.1.0²,¹².0⁴,⁸]hexadecan]-2'(12')-en-2-one

C35H52O3 (520.3916)


   

5-[7-({2-hydroxy-2-methyl-3-[(2-methylbut-2-enoyl)oxy]butanoyl}oxy)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

5-[7-({2-hydroxy-2-methyl-3-[(2-methylbut-2-enoyl)oxy]butanoyl}oxy)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

C30H48O7 (520.34)


   

2-methyl-2-[(1s,5s,6r,9s,10r,16s)-5,9,10-trimethyl-3-oxo-13-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadec-13-en-6-yl]propanoic acid

2-methyl-2-[(1s,5s,6r,9s,10r,16s)-5,9,10-trimethyl-3-oxo-13-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadec-13-en-6-yl]propanoic acid

C30H48O7 (520.34)


   

7-(acetyloxy)-1-(3,6-dihydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

7-(acetyloxy)-1-(3,6-dihydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C31H52O6 (520.3764)


   

3a,7,8-trihydroxy-1-[5-(4-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

3a,7,8-trihydroxy-1-[5-(4-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C30H48O7 (520.34)


   

(1r,3s,4r,8s,10r,11s,14r)-4-hydroxy-10,11-dimethyl-7-methylidene-2,5-dioxatetracyclo[8.4.0.0¹,³.0⁴,⁸]tetradecan-14-yl (2r,3s,4e)-3-hydroxy-6-(hydroxymethyl)-2,4-dimethyldodec-4-enoate

(1r,3s,4r,8s,10r,11s,14r)-4-hydroxy-10,11-dimethyl-7-methylidene-2,5-dioxatetracyclo[8.4.0.0¹,³.0⁴,⁸]tetradecan-14-yl (2r,3s,4e)-3-hydroxy-6-(hydroxymethyl)-2,4-dimethyldodec-4-enoate

C30H48O7 (520.34)


   

(1s,3br,4r,5as,7r,9as,9bs,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

(1s,3br,4r,5as,7r,9as,9bs,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

C31H52O6 (520.3764)


   

(1r,2r,4s,8r,10r,14s,17s,18r)-14-hydroxy-2,6,6,18-tetramethyl-17-[(2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl]-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one

(1r,2r,4s,8r,10r,14s,17s,18r)-14-hydroxy-2,6,6,18-tetramethyl-17-[(2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl]-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one

C30H48O7 (520.34)


   

methyl (1r,2r,4as,6ar,6br,8ar,10s,12ar,12br,14ar,14bs)-1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-hexadecahydropicene-4a-carboxylate

methyl (1r,2r,4as,6ar,6br,8ar,10s,12ar,12br,14ar,14bs)-1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-hexadecahydropicene-4a-carboxylate

C31H52O6 (520.3764)


   

n-{15-[1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl}benzenecarboximidic acid

n-{15-[1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl}benzenecarboximidic acid

C33H48N2O3 (520.3665)


   

1,10,11-trihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

1,10,11-trihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


   

3,4-dihydroxycinnamic acid; behenic acid

3,4-dihydroxycinnamic acid; behenic acid

C31H52O6 (520.3764)


   

(1r,2r,3as,3br,7s,8s,9ar,9br,11ar)-1-[(2r)-2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl]-2,7,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

(1r,2r,3as,3br,7s,8s,9ar,9br,11ar)-1-[(2r)-2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl]-2,7,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C30H48O7 (520.34)


   

2,22,23-trihydroxy-2,6,10,15,19,23-hexamethyltetracosa-6,10,14,18-tetraen-3-yl acetate

2,22,23-trihydroxy-2,6,10,15,19,23-hexamethyltetracosa-6,10,14,18-tetraen-3-yl acetate

C32H56O5 (520.4128)


   

(3s,4s,5e)-6-[(1r,2s,3r,5r,6s,9r,10r,13s,15s,17s)-3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl]-2-methylhept-5-ene-2,3,4-triol

(3s,4s,5e)-6-[(1r,2s,3r,5r,6s,9r,10r,13s,15s,17s)-3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl]-2-methylhept-5-ene-2,3,4-triol

C31H52O6 (520.3764)


   

20-hydroxyecdysone-20,22-monoacetonide

NA

C30H48O7 (520.34)


{"Ingredient_id": "HBIN003411","Ingredient_name": "20-hydroxyecdysone-20,22-monoacetonide","Alias": "NA","Ingredient_formula": "C30H48O7","Ingredient_Smile": "CC1(OC(C(O1)(C)C2CCC3(C2(CCC4C3=CC(=O)C5C4(CC(C(C5)O)O)C)C)O)CCC(C)(C)O)C","Ingredient_weight": "520.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10064","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101243097","DrugBank_id": "NA"}

   

20-hydroxyecdysone-2,3,acetonide

NA

C30H48O7 (520.34)


{"Ingredient_id": "HBIN003413","Ingredient_name": "20-hydroxyecdysone-2,3,acetonide","Alias": "NA","Ingredient_formula": "C30H48O7","Ingredient_Smile": "CC1(OC2CC3C(=O)C=C4C(C3(CC2O1)C)CCC5(C4(CCC5C(C)(C(CCC(C)(C)O)O)O)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42190","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

21-o-methyl toosendanpentaol

NA

C31H52O6 (520.3764)


{"Ingredient_id": "HBIN003594","Ingredient_name": "21-o-methyl toosendanpentaol","Alias": "NA","Ingredient_formula": "C31H52O6","Ingredient_Smile": "CC1(C(CCC2(C1CC(C3(C2CCC4(C3=CCC4C5CC(OC5OC)C(C(C)(C)O)O)C)C)O)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31684","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

21-o-methyl toosendanpentol

21- o -methyltoosendanpentol

C31H52O6 (520.3764)


{"Ingredient_id": "HBIN003595","Ingredient_name": "21-o-methyl toosendanpentol","Alias": "21- o -methyltoosendanpentol","Ingredient_formula": "C31H52O6","Ingredient_Smile": "CC1(C(CCC2(C1CC(C3(C2CCC4(C3=CCC4C5CC(OC5OC)C(C(C)(C)O)O)C)C)O)C)O)C","Ingredient_weight": "520.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT16725","TCMID_id": "14756","TCMSP_id": "NA","TCM_ID_id": "8771","PubChem_id": "101437871","DrugBank_id": "NA"}

   

5,8,10,11-tetrahydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

5,8,10,11-tetrahydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


   

14-hydroxy-2,6,6,18-tetramethyl-17-(2,3,6-trihydroxy-6-methylheptan-2-yl)-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one

14-hydroxy-2,6,6,18-tetramethyl-17-(2,3,6-trihydroxy-6-methylheptan-2-yl)-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one

C30H48O7 (520.34)


   

(4s,5e)-6-[(1r,2s,3r,5r,6s,9r,10r,13s,15s)-3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl]-2-methylhept-5-ene-2,3,4-triol

(4s,5e)-6-[(1r,2s,3r,5r,6s,9r,10r,13s,15s)-3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl]-2-methylhept-5-ene-2,3,4-triol

C31H52O6 (520.3764)


   

(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,7r,9as,9bs,11as)-2,7-dihydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-hydroxy-2,3,4-trimethylpentyl acetate

(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,7r,9as,9bs,11as)-2,7-dihydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-hydroxy-2,3,4-trimethylpentyl acetate

C31H52O6 (520.3764)


   

1-{2,7-dihydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-4-hydroxy-2,3,4-trimethylpentyl acetate

1-{2,7-dihydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-4-hydroxy-2,3,4-trimethylpentyl acetate

C31H52O6 (520.3764)


   

4-hydroxy-9a,11a-dimethyl-7-oxo-1-(3,5,6-trihydroxy-5,6-dimethylheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9-yl acetate

4-hydroxy-9a,11a-dimethyl-7-oxo-1-(3,5,6-trihydroxy-5,6-dimethylheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9-yl acetate

C30H48O7 (520.34)


   

(1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


   

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s,5s)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s,5s)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

C31H52O6 (520.3764)


   

2-methyl-2-[5,9,10-trimethyl-3-oxo-13-(4,5,6-trihydroxy-6-methylheptan-2-yl)-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadec-13-en-6-yl]propanoic acid

2-methyl-2-[5,9,10-trimethyl-3-oxo-13-(4,5,6-trihydroxy-6-methylheptan-2-yl)-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadec-13-en-6-yl]propanoic acid

C30H48O7 (520.34)


   

1-(2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl)-2,7,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-4-one

1-(2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl)-2,7,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-4-one

C30H48O7 (520.34)


   

4-hydroxy-2-methyl-6-{3,4,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-10-oxo-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}heptanoic acid

4-hydroxy-2-methyl-6-{3,4,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-10-oxo-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}heptanoic acid

C30H48O7 (520.34)


   

2-methyl-4-oxo-6-{3,4,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-10-oxo-dodecahydrocyclopenta[a]phenanthren-1-yl}heptanoic acid

2-methyl-4-oxo-6-{3,4,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-10-oxo-dodecahydrocyclopenta[a]phenanthren-1-yl}heptanoic acid

C30H48O7 (520.34)


   

(1s,3s,4s,6s,7s,8r,11s,12s,15r,16r)-15-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-4,6-dihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

(1s,3s,4s,6s,7s,8r,11s,12s,15r,16r)-15-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-4,6-dihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O6 (520.3764)


   

1,10,11,12-tetrahydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

1,10,11,12-tetrahydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


   

(1r,2r,3s,4s,5s,7r,8s,11r,12s,17r)-12-(acetyloxy)-5,8,11-trimethyl-15-methylidene-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl (2r)-2-hydroxyoctanoate

(1r,2r,3s,4s,5s,7r,8s,11r,12s,17r)-12-(acetyloxy)-5,8,11-trimethyl-15-methylidene-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl (2r)-2-hydroxyoctanoate

C30H48O7 (520.34)


   

(1r,2r,4as,6as,6br,8ar,9r,10r,11r,12r,12ar,12bs,14bs)-1,10,11,12-tetrahydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(1r,2r,4as,6as,6br,8ar,9r,10r,11r,12r,12ar,12bs,14bs)-1,10,11,12-tetrahydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


   

(1r,3as,5ar,7r,8s,9ar,9bs,11ar)-3a,7,8-trihydroxy-1-[(4r,5s)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

(1r,3as,5ar,7r,8s,9ar,9bs,11ar)-3a,7,8-trihydroxy-1-[(4r,5s)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C30H48O7 (520.34)


   

3a,7,8-trihydroxy-1-[5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

3a,7,8-trihydroxy-1-[5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C30H48O7 (520.34)


   

2-({1-ethenyl-7-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-6-yl}oxy)-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

2-({1-ethenyl-7-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-6-yl}oxy)-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C30H48O7 (520.34)


   

5-{4-hydroxy-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-5-{[(3-methylbutanoyl)oxy]methyl}-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}-3-methylpent-2-enoic acid

5-{4-hydroxy-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-5-{[(3-methylbutanoyl)oxy]methyl}-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}-3-methylpent-2-enoic acid

C30H48O7 (520.34)


   

(1s,3as,3br,4r,9s,9as,9bs,11as)-4-hydroxy-9a,11a-dimethyl-7-oxo-1-[(2s,3r,5r)-3,5,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9-yl acetate

(1s,3as,3br,4r,9s,9as,9bs,11as)-4-hydroxy-9a,11a-dimethyl-7-oxo-1-[(2s,3r,5r)-3,5,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9-yl acetate

C30H48O7 (520.34)


   

(2r,3s,4ar,6r,8s,8ar)-3,6-dihydroxy-8-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-4,4-dimethyl-8a-({[(2r)-2-methylbutanoyl]oxy}methyl)-7-methylidene-hexahydro-1h-naphthalen-2-yl (2z)-2-methylbut-2-enoate

(2r,3s,4ar,6r,8s,8ar)-3,6-dihydroxy-8-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-4,4-dimethyl-8a-({[(2r)-2-methylbutanoyl]oxy}methyl)-7-methylidene-hexahydro-1h-naphthalen-2-yl (2z)-2-methylbut-2-enoate

C30H48O7 (520.34)


   

(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s)-6-hydroperoxy-2-hydroxy-6-methylheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s)-6-hydroperoxy-2-hydroxy-6-methylheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

C32H56O5 (520.4128)


   

(4ar,6as,6br,8ar,12ar,12bs,14bs)-5,10,11-trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4ar,6as,6br,8ar,12ar,12bs,14bs)-5,10,11-trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


   

1-(6-hydroperoxy-2-hydroxy-6-methylheptan-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

1-(6-hydroperoxy-2-hydroxy-6-methylheptan-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

C32H56O5 (520.4128)


   

3,6-dihydroxy-8-(3-hydroxy-3-methylpent-4-en-1-yl)-4,4-dimethyl-8a-{[(2-methylbutanoyl)oxy]methyl}-7-methylidene-hexahydro-1h-naphthalen-2-yl 2-methylbut-2-enoate

3,6-dihydroxy-8-(3-hydroxy-3-methylpent-4-en-1-yl)-4,4-dimethyl-8a-{[(2-methylbutanoyl)oxy]methyl}-7-methylidene-hexahydro-1h-naphthalen-2-yl 2-methylbut-2-enoate

C30H48O7 (520.34)


   

3a,6,6,9a,11a-pentamethyl-1-(2,5,6-trihydroxy-6-methylheptan-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

3a,6,6,9a,11a-pentamethyl-1-(2,5,6-trihydroxy-6-methylheptan-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

C32H56O5 (520.4128)


   

(2r,4s,6r)-6-[(1r,3s,3ar,4s,5ar,7s,9as,11ar)-3,4,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-10-oxo-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-2-methylheptanoic acid

(2r,4s,6r)-6-[(1r,3s,3ar,4s,5ar,7s,9as,11ar)-3,4,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-10-oxo-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-2-methylheptanoic acid

C30H48O7 (520.34)


   

1-[5-(7-hydroxy-2,5,8a-trimethyl-5-{[(3-methylbutanoyl)oxy]methyl}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpent-2-en-1-yl] 4-methyl butanedioate

1-[5-(7-hydroxy-2,5,8a-trimethyl-5-{[(3-methylbutanoyl)oxy]methyl}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpent-2-en-1-yl] 4-methyl butanedioate

C30H48O7 (520.34)


   

(1's,2s,2's,4s,4's,7'r,8'r,9's,11's,12's,13's,15'r,16's,18's)-7',11',16'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-yl acetate

(1's,2s,2's,4s,4's,7'r,8'r,9's,11's,12's,13's,15'r,16's,18's)-7',11',16'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-yl acetate

C30H48O7 (520.34)


   

7',11',16'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-yl acetate

7',11',16'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-yl acetate

C30H48O7 (520.34)


   

(1r,2r,3as,3bs,7s,8s,9ar,9br,11ar)-1-[(2r)-2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl]-2,7,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

(1r,2r,3as,3bs,7s,8s,9ar,9br,11ar)-1-[(2r)-2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl]-2,7,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C30H48O7 (520.34)


   

5a,7,8-trihydroxy-1-[5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

5a,7,8-trihydroxy-1-[5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C30H48O7 (520.34)


   

(2r)-2,5,7,8-tetramethyl-2-[(4r,8r,11s)-8,11,12-trihydroxy-4,8,12-trimethyltridecyl]-3,4-dihydro-1-benzopyran-6-yl acetate

(2r)-2,5,7,8-tetramethyl-2-[(4r,8r,11s)-8,11,12-trihydroxy-4,8,12-trimethyltridecyl]-3,4-dihydro-1-benzopyran-6-yl acetate

C31H52O6 (520.3764)


   

(1s,3as,3br,5ar,7r,9ar,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2s,5s)-2,5,6-trihydroxy-6-methylheptan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3as,3br,5ar,7r,9ar,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2s,5s)-2,5,6-trihydroxy-6-methylheptan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

C32H56O5 (520.4128)


   

7',11',15'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-yl acetate

7',11',15'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-yl acetate

C30H48O7 (520.34)


   

(1's,2r,2's,4s,4'r,7'r,8'r,9's,11's,12's,13's,15'r,16's,18's)-7',11',16'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-yl acetate

(1's,2r,2's,4s,4'r,7'r,8'r,9's,11's,12's,13's,15'r,16's,18's)-7',11',16'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-yl acetate

C30H48O7 (520.34)


   

(4ar,5r,6as,6br,8r,8ar,9r,10r,11s,12ar,12br,14bs)-5,8,10,11-tetrahydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4ar,5r,6as,6br,8r,8ar,9r,10r,11s,12ar,12br,14bs)-5,8,10,11-tetrahydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


   

(1s,3as,3br,4r,9s,9as,9bs,11as)-4-hydroxy-9a,11a-dimethyl-7-oxo-1-[(2s,3r,5s)-3,5,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9-yl acetate

(1s,3as,3br,4r,9s,9as,9bs,11as)-4-hydroxy-9a,11a-dimethyl-7-oxo-1-[(2s,3r,5s)-3,5,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9-yl acetate

C30H48O7 (520.34)


   

6-(4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl)-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

6-(4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl)-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

C31H52O6 (520.3764)


   

(1r,3ar,3br,5s,5ar,7r,9ar,9bs,11as)-7-(acetyloxy)-1-[(2s,3s)-3,6-dihydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

(1r,3ar,3br,5s,5ar,7r,9ar,9bs,11as)-7-(acetyloxy)-1-[(2s,3s)-3,6-dihydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C31H52O6 (520.3764)


   

3-(1-hydroxypropan-2-ylidene)-4a,5-dimethyl-2-oxo-hexahydronaphtho[1,8a-b]oxiren-8-yl 3-hydroxy-6-(hydroxymethyl)-2,4-dimethyldodec-4-enoate

3-(1-hydroxypropan-2-ylidene)-4a,5-dimethyl-2-oxo-hexahydronaphtho[1,8a-b]oxiren-8-yl 3-hydroxy-6-(hydroxymethyl)-2,4-dimethyldodec-4-enoate

C30H48O7 (520.34)


   

6-{3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl}-2-methylhept-5-ene-2,3,4-triol

6-{3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl}-2-methylhept-5-ene-2,3,4-triol

C31H52O6 (520.3764)


   

(1s,4ar,6as,6br,8ar,10s,11r,12ar,12br,14bs)-1,10,11-trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(1s,4ar,6as,6br,8ar,10s,11r,12ar,12br,14bs)-1,10,11-trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


   

(1's,2s,2's,4s,4's,7'r,8'r,9's,11's,12's,13's,15'r,16's,18's)-7',11',15'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-yl acetate

(1's,2s,2's,4s,4's,7'r,8'r,9's,11's,12's,13's,15'r,16's,18's)-7',11',15'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-yl acetate

C30H48O7 (520.34)


   

n-[(6s,7r,8r,11s,12s,14r,15s,16r)-15-[(1r)-1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl]benzenecarboximidic acid

n-[(6s,7r,8r,11s,12s,14r,15s,16r)-15-[(1r)-1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl]benzenecarboximidic acid

C33H48N2O3 (520.3665)


   

(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-trihydroxy-1-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-trihydroxy-1-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C30H48O7 (520.34)


   

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3r,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3r,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

C31H52O6 (520.3764)


   

n-{15-[1-(dimethylamino)ethyl]-5-hydroxy-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}-n-methylbenzamide

n-{15-[1-(dimethylamino)ethyl]-5-hydroxy-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}-n-methylbenzamide

C34H52N2O2 (520.4029)


   

(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-trihydroxy-1-[(4r,5r)-5-[(3s)-4-hydroxy-3-methylbutyl]-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-trihydroxy-1-[(4r,5r)-5-[(3s)-4-hydroxy-3-methylbutyl]-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C30H48O7 (520.34)


   

4-hydroxy-10,11-dimethyl-7-methylidene-2,5-dioxatetracyclo[8.4.0.0¹,³.0⁴,⁸]tetradecan-14-yl 3-hydroxy-6-(hydroxymethyl)-2,4-dimethyldodec-4-enoate

4-hydroxy-10,11-dimethyl-7-methylidene-2,5-dioxatetracyclo[8.4.0.0¹,³.0⁴,⁸]tetradecan-14-yl 3-hydroxy-6-(hydroxymethyl)-2,4-dimethyldodec-4-enoate

C30H48O7 (520.34)


   

(8s,20z,31r,32z)-pentatriaconta-20,32-dien-2,4,6,34-tetrayne-1,8,31-triol

(8s,20z,31r,32z)-pentatriaconta-20,32-dien-2,4,6,34-tetrayne-1,8,31-triol

C35H52O3 (520.3916)


   

12-(acetyloxy)-5,8,11-trimethyl-15-methylidene-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl 2-hydroxyoctanoate

12-(acetyloxy)-5,8,11-trimethyl-15-methylidene-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl 2-hydroxyoctanoate

C30H48O7 (520.34)


   

n-[(6s,7r,8r,11r,12s,14r,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3-dien-6-yl]benzenecarboximidic acid

n-[(6s,7r,8r,11r,12s,14r,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3-dien-6-yl]benzenecarboximidic acid

C33H48N2O3 (520.3665)


   

(1r,2r,4as,6as,6br,8ar,10s,11r,12ar,12br,14bs)-1,10,11-trihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(1r,2r,4as,6as,6br,8ar,10s,11r,12ar,12br,14bs)-1,10,11-trihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


   

1-[5-(1,2-dihydroxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

1-[5-(1,2-dihydroxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

C31H52O6 (520.3764)


   

(1r,3s,4r,8s,10r,11s,14r)-4-hydroxy-10,11-dimethyl-7-methylidene-2,5-dioxatetracyclo[8.4.0.0¹,³.0⁴,⁸]tetradecan-14-yl (2r,3s,4e,6r)-3-hydroxy-6-(hydroxymethyl)-2,4-dimethyldodec-4-enoate

(1r,3s,4r,8s,10r,11s,14r)-4-hydroxy-10,11-dimethyl-7-methylidene-2,5-dioxatetracyclo[8.4.0.0¹,³.0⁴,⁸]tetradecan-14-yl (2r,3s,4e,6r)-3-hydroxy-6-(hydroxymethyl)-2,4-dimethyldodec-4-enoate

C30H48O7 (520.34)


   

(1's,2r,2's,4s,4's,7'r,8'r,9's,11's,12's,13's,15'r,16's,18's)-7',11',15'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-yl acetate

(1's,2r,2's,4s,4's,7'r,8'r,9's,11's,12's,13's,15'r,16's,18's)-7',11',15'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-yl acetate

C30H48O7 (520.34)


   

(3r,6e,10e,14e,18e,22r)-2,22,23-trihydroxy-2,6,10,15,19,23-hexamethyltetracosa-6,10,14,18-tetraen-3-yl acetate

(3r,6e,10e,14e,18e,22r)-2,22,23-trihydroxy-2,6,10,15,19,23-hexamethyltetracosa-6,10,14,18-tetraen-3-yl acetate

C32H56O5 (520.4128)


   

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

C31H52O6 (520.3764)


   

(3r)-5-[(1r,4ar,7s,8as)-7-{[(2s,3r)-2-hydroxy-2-methyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}butanoyl]oxy}-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

(3r)-5-[(1r,4ar,7s,8as)-7-{[(2s,3r)-2-hydroxy-2-methyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}butanoyl]oxy}-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

C30H48O7 (520.34)


   

5-[5-(hydroxymethyl)-2,5,8a-trimethyl-4,6-bis[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

5-[5-(hydroxymethyl)-2,5,8a-trimethyl-4,6-bis[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C30H48O7 (520.34)


   

n-(5-{4-[(5-amino-1-hydroxypentyl)amino]-n,2-dihydroxybutanamido}pentyl)-3-[(5-aminopentyl)(hydroxy)carbamoyl]propanimidic acid

n-(5-{4-[(5-amino-1-hydroxypentyl)amino]-n,2-dihydroxybutanamido}pentyl)-3-[(5-aminopentyl)(hydroxy)carbamoyl]propanimidic acid

C23H48N6O7 (520.3584)


   

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3r,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3r,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

C31H52O6 (520.3764)


   

(1s,3as,5ar,7r,8s,9ar,9br,10r,11ar)-3a,7,8,10-tetrahydroxy-9a,11a-dimethyl-1-[(4r,5r)-2,2,4-trimethyl-5-(3-methylbutyl)-1,3-dioxolan-4-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

(1s,3as,5ar,7r,8s,9ar,9br,10r,11ar)-3a,7,8,10-tetrahydroxy-9a,11a-dimethyl-1-[(4r,5r)-2,2,4-trimethyl-5-(3-methylbutyl)-1,3-dioxolan-4-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C30H48O7 (520.34)


   

(1as,4ar,5s,8r,8ar)-3-(1-hydroxypropan-2-ylidene)-4a,5-dimethyl-2-oxo-hexahydronaphtho[1,8a-b]oxiren-8-yl (2r,3s,6s)-3-hydroxy-6-(hydroxymethyl)-2,4-dimethyldodec-4-enoate

(1as,4ar,5s,8r,8ar)-3-(1-hydroxypropan-2-ylidene)-4a,5-dimethyl-2-oxo-hexahydronaphtho[1,8a-b]oxiren-8-yl (2r,3s,6s)-3-hydroxy-6-(hydroxymethyl)-2,4-dimethyldodec-4-enoate

C30H48O7 (520.34)


   

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s,5r)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s,5r)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

C31H52O6 (520.3764)


   

(1s,3br,4r,5ar,7r,9as,9bs,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

(1s,3br,4r,5ar,7r,9as,9bs,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

C31H52O6 (520.3764)


   

methyl 1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-hexadecahydropicene-4a-carboxylate

methyl 1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-hexadecahydropicene-4a-carboxylate

C31H52O6 (520.3764)


   

(1s,2s,3r,4r,5r,7s,8r,11s,12r,14r,17s)-4-(acetyloxy)-14-hydroxy-5,8,11-trimethyl-15-methylidene-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-12-yl octanoate

(1s,2s,3r,4r,5r,7s,8r,11s,12r,14r,17s)-4-(acetyloxy)-14-hydroxy-5,8,11-trimethyl-15-methylidene-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-12-yl octanoate

C30H48O7 (520.34)


   

(1r,3as,5ar,7r,8s,9ar,9bs,10r,11ar)-3a,7,8,10-tetrahydroxy-9a,11a-dimethyl-1-[(4r,5s)-2,2,4-trimethyl-5-(3-methylbutyl)-1,3-dioxolan-4-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

(1r,3as,5ar,7r,8s,9ar,9bs,10r,11ar)-3a,7,8,10-tetrahydroxy-9a,11a-dimethyl-1-[(4r,5s)-2,2,4-trimethyl-5-(3-methylbutyl)-1,3-dioxolan-4-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C30H48O7 (520.34)


   

(2e)-5-[(4r,4ar,5s,6r,8as)-5-(hydroxymethyl)-2,5,8a-trimethyl-4,6-bis[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

(2e)-5-[(4r,4ar,5s,6r,8as)-5-(hydroxymethyl)-2,5,8a-trimethyl-4,6-bis[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C30H48O7 (520.34)


   

(1s,4ar,6as,6br,8r,8ar,9s,10r,11r,12ar,12br,14bs)-1,8,10,11-tetrahydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(1s,4ar,6as,6br,8r,8ar,9s,10r,11r,12ar,12br,14bs)-1,8,10,11-tetrahydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


   

(20z,31e)-pentatriaconta-20,31-dien-2,4,22,34-tetrayne-1,6,33-triol

(20z,31e)-pentatriaconta-20,31-dien-2,4,22,34-tetrayne-1,6,33-triol

C35H52O3 (520.3916)


   

3a,7,8,10-tetrahydroxy-9a,11a-dimethyl-1-[2,2,4-trimethyl-5-(3-methylbutyl)-1,3-dioxolan-4-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

3a,7,8,10-tetrahydroxy-9a,11a-dimethyl-1-[2,2,4-trimethyl-5-(3-methylbutyl)-1,3-dioxolan-4-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C30H48O7 (520.34)


   

(1r,2r,3as,3br,7r,8s,9as,9bs,11ar)-1-[(2r)-2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl]-2,7,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,2r,3as,3br,7r,8s,9as,9bs,11ar)-1-[(2r)-2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl]-2,7,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-4-one

C30H48O7 (520.34)


   

(2e)-5-[(4r,4ar,5s,6r,8as)-4-hydroxy-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-5-{[(3-methylbutanoyl)oxy]methyl}-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

(2e)-5-[(4r,4ar,5s,6r,8as)-4-hydroxy-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-5-{[(3-methylbutanoyl)oxy]methyl}-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C30H48O7 (520.34)


   

n-[(1s,3s,5r,6r,8r,11s,12s,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-5-hydroxy-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]-n-methylbenzamide

n-[(1s,3s,5r,6r,8r,11s,12s,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-5-hydroxy-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]-n-methylbenzamide

C34H52N2O2 (520.4029)


   

(1s,3ar,5as,7r,8s,9ar,9bs,11as)-5a,7,8-trihydroxy-1-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

(1s,3ar,5as,7r,8s,9ar,9bs,11as)-5a,7,8-trihydroxy-1-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C30H48O7 (520.34)


   

(1's,2r,2's,4s,4's,7'r,8'r,9's,11's,12's,13's,15'r,16's,18's)-7',11',16'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-yl acetate

(1's,2r,2's,4s,4's,7'r,8'r,9's,11's,12's,13's,15'r,16's,18's)-7',11',16'-trihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-yl acetate

C30H48O7 (520.34)


   

(1r,2r,4as,6as,6br,8as,9r,10r,11r,12r,12ar,12br,14bs)-1,10,11,12-tetrahydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(1r,2r,4as,6as,6br,8as,9r,10r,11r,12r,12ar,12br,14bs)-1,10,11,12-tetrahydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C30H48O7 (520.34)


   

1-(2e)-5-[(1s,4ar,5s,7r,8ar)-7-hydroxy-2,5,8a-trimethyl-5-{[(3-methylbutanoyl)oxy]methyl}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl 4-methyl butanedioate

1-(2e)-5-[(1s,4ar,5s,7r,8ar)-7-hydroxy-2,5,8a-trimethyl-5-{[(3-methylbutanoyl)oxy]methyl}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl 4-methyl butanedioate

C30H48O7 (520.34)